Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A new prognostic scoring scale for patients with primary WHO grade III gliomas based on molecular predictors.

Journal of neuro-oncology - 1 Feb 2013

Jiang Haihui, Ren Xiaohui, Zhang Wei, Ma Jun, Sui Dali, Jiang Zhongli, Cui Xiangli, Lin Song

Abstract excerpt

This study was designed to select molecular markers associated with prognosis, and to propose a prognostic scoring scale for patients with primary WHO grade III gliomas based on these molecular predictors. A series of 83 grade III glioma patients surgically treated and pathologically confirmed in Beijing Tiantan Hospital between May 2009 and December 2010 were retrospectively reviewed in the study. Log-rank...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Chromosome Deletion

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosomes, Human, Pair 1

Share to Disease-Free Survival

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Regression Analysis

Share to Survival Analysis

Source

Identifiers

PMID: 23269453
DOI: 10.1007/s11060-012-1026-x

Genes

EGFR
IDH1
MGMT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A new prognostic scoring scale for patients with primary WHO grade III gliomas based on molecular predictors.PMID 23269453Read ↗

Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.Semantic proximity Read ↗

Prognostic Value of a Nomogram Model Based on Tumor Immune Markers and Clinical Factors for Adult Primary GliomasSemantic proximity Read ↗

New molecular prognostic factors of adult diffuse lower-grade gliomas in post-2016 molecular era: a retrospective analysis from single center.Semantic proximity Read ↗

The role of clinical and molecular factors in low-grade gliomas: what is their impact on survival?Semantic proximity Read ↗

Predictors of Survival in Turkish Patients with Primary Glioblastoma.Semantic proximity Read ↗

Integrative analysis of TP73 profile prognostic significance in WHO grade II/III glioma.Semantic proximity Read ↗

Predictive and prognostic factors for gliomas.Semantic proximity Read ↗

Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling.Semantic proximity Read ↗

Identification of a Four-miRNA Risk Score Model and Hub Genes as a Novel Potential Prognostic Biomarker in Patients with GliomaSemantic proximity Read ↗

Clinical prognostic value of isocitrate dehydrogenase mutation, O-6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in glioma patientsSemantic proximity Read ↗

A practical review of prognostic correlations of molecular biomarkers in glioblastomaSemantic proximity Read ↗

IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survival.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.